Quadrantectomy for Breast Cancer: 14 Real Stories

Breast Cancer: Renacer's Survivor Story

Patient Info: Renacer

Renacer was declared cancer-free in September 2017 and continued focusing on exercise, nutrition, family, and fear of recurrence.

Our Cancer StoriesRead more →

Invasive lobular breast cancer with colonic metastases treated with colectomy and capecitabine

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Breast and colon metastatic samples were ER+ and HER2-; PR varied by sample

Metastatic Site: colon; perivisceral lymph nodes

After laparoscopic left colectomy and capecitabine for colonic metastases, follow-up showed no clinical or radiological evidence of recurrence or progression at 8 months postoperatively.

PubMed CentralRead more →

Triple-negative sebaceous carcinoma of the breast: no recurrence after multimodality treatment

Patient Info: Anonymized, Female, Under 40

Biomarkers: Triple-negative sebaceous breast carcinoma; EMA-positive; Ki-67 50-60%; inherited breast/ovarian cancer testing negative for pathogenic variants.

As of May 2025, after surgery, adjuvant chemotherapy, and radiation, she had 5 years of follow-up with no evidence of neoplastic recurrence.

PubMed CentralRead more →

Treating Breast Asymmetry After Breast Cancer Surgery and Radiation

Patient Info: Anonymized, Female, 50s

By February 2024, about 2 years after breast-cancer surgery and radiation, she had completely recovered from the oncological condition.

PubMed CentralRead more →

New Triple-Negative Breast Cancer Develops During Olaparib Treatment for a Separate Lung Cancer

Patient Info: Anonymized, female, 60s

Biomarkers: Triple-negative; germline BRCA2 mutation; BRCA2 reversion mutation

A woman receiving olaparib for BRCA2-mutated metastatic lung cancer developed a separate 14 mm triple-negative breast cancer with a BRCA2 reversion mutation.

PubMed CentralRead more →

Stage III Breast Cancer: Diana's Patient Story

Patient Info: Diana, Female, 40s | Stage III

As of 2023, Diana was receiving treatment for Stage III breast cancer after quadrantectomy, chemotherapy, radiation therapy, hormone therapy, unilateral oncological mammoplasty, and lymph-node removal.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Audrey's Patient Story

Patient Info: Audrey, Female, 60s | Stage I

Audrey completed quadrantectomy and radiation therapy for Stage I breast cancer and remained on hormone therapy, with lymphatic drainage and physical therapy for lymphedema and pain-related effects.

Our Cancer StoriesRead more →

Metastatic Lobular Breast Cancer With Long-Term Disease Control Across Multiple Therapies

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: Initial tumor: ER negative, HER2 negative, Ki67 17%. 2006 recurrence: ER 40%

Metastatic Site: pleura, liver, skin, bone

She was alive on ongoing metronomic vinorelbine with substantial disease stabilization at the most recent follow-up.

PubMed CentralRead more →

Recurrent Breast Cancer With Liver Metastases Treated Through Multiple Chemotherapy Lines

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: Initial tumor: ER positive, HER2 0. Liver metastasis: ER 100%

Metastatic Site: liver

After liver progression following 18 cycles of eribulin, she started weekly carboplatin and remained in active treatment.

PubMed CentralRead more →

Metastatic Breast Cancer With Durable Liver and Peritoneal Response to Eribulin

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: Initial tumor: ER 90%, PgR 70%. Liver metastasis: ER 60%, HER2 1+

Metastatic Site: liver, peritoneum

While continuing eribulin beyond 34 cycles, her liver disease was stable and the peritoneal response persisted after earlier major tumor reduction.

PubMed CentralRead more →

Metastatic Breast Cancer Responding to Eribulin After Repeated Liver Progression

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: ER 100%, HER2 negative

Metastatic Site: bone, liver

Eribulin remained ongoing with repeated partial responses documented through 12 cycles and no need for dose reduction.

PubMed CentralRead more →

HER2-Positive Recurrent Breast Cancer Treated With Multiple Targeted and Local Therapies

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: 2008 recurrence: ER 80%, HER2 FISH amplified. 2011 recurrence: ER 80%

Metastatic Site: liver, skin

After 25 cycles of eribulin, treatment was still ongoing; nodal disease remained stable, while later imaging also noted new metabolic activity in the upper lung.

PubMed CentralRead more →

Stage II Breast Cancer: Natalia's Survivor Story

Patient Info: Natalia | Stage II

Natalia was declared cancer-free on February 21, 2024, and continued regular follow-up while taking letrozole.

Our Cancer StoriesRead more →

Metastatic lobular breast cancer to gynecologic sites: disease-free after surgery and chemotherapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-negative; HER2/C-Erb-B2-negative

Metastatic Site: vagina, uterus, ovaries

After treatment of vaginal, uterine, and ovarian metastases from lobular breast cancer, she was free from disease 12 months after completion surgery.

PubMed CentralRead more →